<p>/PRNewswire/ -- Clordisys Solutions, LLC 是一家领先的二氧化氯气体合同灭菌服务提供商，是环氧乙烷（EO）的成熟替代方案，今天宣布两位前 Sterigenics 领导者 Cody Lane 和 Kenneth Allen 加入其执行团队。</p>
<p>这一领导层扩展反映了 Clordisys 在商业运营、扩展产能以及支持其现有合同灭菌平台和未来设施日益增长的需求方面的持续发展。</p>
<p>Lane 和 Allen 的加入进一步巩固了 Clordisys 作为复杂医疗设备和制药产品的商业规模合同灭菌提供商的地位。</p>
<p><strong>Cody Lane</strong>，业务发展总监，加入 Clordisys 以指导客户在可行性、验证以及长期商业和合同关系方面的参与。Lane 拥有超过 14 年的技术和商业经验，涵盖生物制品、医疗设备和合同灭菌。他的背景包括在 Sterigenics 工作超过六年，支持制药和医疗设备制造商在环氧乙烷、伽马射线、X 射线和电子束灭菌方式下的需求，以及在生物制品制造、研发支持和内部灭菌操作方面的丰富经验。</p>
<p>Lane 在灭菌科学、监管期望和实际实施方面的专业知识支持客户从开发项目过渡到经过验证的、可扩展的商业处理，特别是在有效的 EO 替代品需求持续增长的情况下。</p>
<p><strong>Kenneth Allen</strong>，运营副总裁，拥有超过 33 年的生命科学和医疗技术领域的领导经验，包括在 Sterigenics、Arrow International、Boston Scientific、Fresenius Medical Care、bioMérieux、AstraZeneca 和 Integra Life Sciences 担任运营、质量和总管理等高级职务。Allen 负责 Clordisys 合同灭菌业务的商业运营，强化了一个专注于产量、可靠性和可扩展性的运营基础。</p>
<p>Allen 的经验包括直接领导环氧乙烷、伽马射线和蒸汽灭菌设施，以及大规模的整改工作、质量体系转型、数字化现代化和运营卓越计划。他的运营领导支持持续的产能扩展和严谨的执行，随着额外的灭菌设施投入使用。</p>
<p>“这些新增成员代表了 Clordisys 持续增长的重要一步，” Clordisys 首席执行官 Mark Lecher 表示。“Cody 和 Ken 带来了深厚的灭菌专业知识、运营纪律和行业信誉。他们的领导增强了我们为客户提供一致性能、监管信心和可扩展产能的能力。”</p>
<p>领导层扩展紧随 Clordisys 新网站和品牌形象更新的推出，反映了公司作为专注于安全、可扩展性和运营卓越的合同灭菌合作伙伴的持续演变。</p>
<p>随着领导层深度和运营实力的增强，Clordisys 继续推动二氧化氯气体灭菌作为全球医疗设备和制药制造商可行的高产量 EO 替代方案。</p>
<p>联系方式：Emily Lorcheim，ClorDiSys，电话：908-236-4100，[email protected]，50 Tannery Rd, Suite 1, Branchburg, NJ 08876</p>
<p>来源：ClorDiSys Solutions Inc</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEwJk5ld3NJdGVtSWQ9Tlk4NDg4MyZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTAxMzAxUFJfTkVXU19VU1BSX19fX19OWTg0ODgz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEwJk5ld3NJdGVtSWQ9Tlk4NDg4MyZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTAxMzAxUFJfTkVXU19VU1BSX19fX19OWTg0ODgz"/></p>

<p>Clordisys Solutions, LLC 通过引入前 Sterigenics 的领导者 Cody Lane 和 Kenneth Allen 来扩展其领导团队，以支持其合同灭菌业务的增长。Lane 担任业务发展总监，将增强客户参与度，而 Allen 担任运营副总裁，将负责商业运营。这一领导层扩展旨在加强 Clordisys 在合同灭菌市场的地位，特别是在医疗设备和制药领域，因为对二氧化氯气灭菌替代环氧乙烷的需求正在增加</p>

<p>, /PRNewswire/ -- Clordisys Solutions, LLC, a leading provider of chlorine dioxide gas contract sterilization services and an established alternative to ethylene oxide (EO), today announced the addition of Cody Lane and Kenneth Allen, two former Sterigenics leaders, to its executive team.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Clordisys Solutions, LLC 是一家领先的二氧化氯气体合同灭菌服务提供商，是环氧乙烷（EO）的成熟替代方案，今天宣布两位前 Sterigenics 领导者 Cody Lane 和 Kenneth Allen 加入其执行团队。</p>
</div><p>This leadership expansion reflects Clordisys' continued scaling of its commercial operations, expanded capacity, and ability to support increasing demand across its existing contract sterilization platform and future facilities.</p>
<div class="lb-trans"><p>这一领导层扩展反映了 Clordisys 在商业运营、扩展产能以及支持其现有合同灭菌平台和未来设施日益增长的需求方面的持续发展。</p>
</div><p>The addition of Lane and Allen further strengthens Clordisys' position as a commercial-scale contract sterilization provider for complex medical device and pharmaceutical products.</p>
<div class="lb-trans"><p>Lane 和 Allen 的加入进一步巩固了 Clordisys 作为复杂医疗设备和制药产品的商业规模合同灭菌提供商的地位。</p>
</div><p><strong>Cody Lane</strong>, Director of Business Development, joins Clordisys to guide customer engagement across feasibility, validation, and long-term commercial and contractual relationships. Lane brings more than 14 years of technical and commercial experience spanning biologics, medical devices, and contract sterilization. His background includes more than six years at Sterigenics supporting pharmaceutical and medical device manufacturers across ethylene oxide, gamma, X-ray, and E-beam sterilization modalities, as well as extensive experience in biologics manufacturing, R&amp;D support, and in-house sterilization operations.</p>
<div class="lb-trans"><p><strong>Cody Lane</strong>，业务发展总监，加入 Clordisys 以指导客户在可行性、验证以及长期商业和合同关系方面的参与。Lane 拥有超过 14 年的技术和商业经验，涵盖生物制品、医疗设备和合同灭菌。他的背景包括在 Sterigenics 工作超过六年，支持制药和医疗设备制造商在环氧乙烷、伽马射线、X 射线和电子束灭菌方式下的需求，以及在生物制品制造、研发支持和内部灭菌操作方面的丰富经验。</p>
</div><p>Lane's expertise in sterilization science, regulatory expectations, and practical implementation supports customers transitioning from development programs into validated, scalable commercial processing, particularly as demand for effective EO alternatives continues to grow.</p>
<div class="lb-trans"><p>Lane 在灭菌科学、监管期望和实际实施方面的专业知识支持客户从开发项目过渡到经过验证的、可扩展的商业处理，特别是在有效的 EO 替代品需求持续增长的情况下。</p>
</div><p><strong>Kenneth Allen</strong>, Vice President of Operations, brings more than 33 years of leadership experience across life sciences and medtech, including senior roles in operations, quality, and general management at Sterigenics, Arrow International, Boston Scientific, Fresenius Medical Care, bioMérieux, AstraZeneca, and Integra Life Sciences. Allen oversees commercial operations across Clordisys' contract sterilization business, reinforcing an operational foundation focused on throughput, reliability, and scalability.</p>
<div class="lb-trans"><p><strong>Kenneth Allen</strong>，运营副总裁，拥有超过 33 年的生命科学和医疗技术领域的领导经验，包括在 Sterigenics、Arrow International、Boston Scientific、Fresenius Medical Care、bioMérieux、AstraZeneca 和 Integra Life Sciences 担任运营、质量和总管理等高级职务。Allen 负责 Clordisys 合同灭菌业务的商业运营，强化了一个专注于产量、可靠性和可扩展性的运营基础。</p>
</div><p>Allen's experience includes direct leadership of ethylene oxide, gamma, and steam sterilization facilities, as well as large-scale remediation efforts, quality system transformation, digital modernization, and operational excellence initiatives. His operational leadership supports continued capacity expansion and disciplined execution as additional sterilization facilities come online.</p>
<div class="lb-trans"><p>Allen 的经验包括直接领导环氧乙烷、伽马射线和蒸汽灭菌设施，以及大规模的整改工作、质量体系转型、数字化现代化和运营卓越计划。他的运营领导支持持续的产能扩展和严谨的执行，随着额外的灭菌设施投入使用。</p>
</div><p>&#34;These additions represent an important step in Clordisys' continued growth,&#34; said Mark Lecher, Chief Executive Officer of Clordisys. &#34;Cody and Ken bring deep sterilization expertise, operational discipline, and industry credibility. Their leadership enhances our ability to deliver consistent performance, regulatory confidence, and scalable capacity for our customers.&#34;</p>
<div class="lb-trans"><p>“这些新增成员代表了 Clordisys 持续增长的重要一步，” Clordisys 首席执行官 Mark Lecher 表示。“Cody 和 Ken 带来了深厚的灭菌专业知识、运营纪律和行业信誉。他们的领导增强了我们为客户提供一致性能、监管信心和可扩展产能的能力。”</p>
</div><p>The leadership expansion closely follows the launch of Clordisys' new website and refreshed brand identity, reflecting the company's continued evolution as a contract sterilization partner focused on safety, scalability, and operational excellence.</p>
<div class="lb-trans"><p>领导层扩展紧随 Clordisys 新网站和品牌形象更新的推出，反映了公司作为专注于安全、可扩展性和运营卓越的合同灭菌合作伙伴的持续演变。</p>
</div><p>With increased leadership depth and operational strength, Clordisys continues to advance chlorine dioxide gas sterilization as a viable, high-throughput EO alternative for medical device and pharmaceutical manufacturers worldwide.</p>
<div class="lb-trans"><p>随着领导层深度和运营实力的增强，Clordisys 继续推动二氧化氯气体灭菌作为全球医疗设备和制药制造商可行的高产量 EO 替代方案。</p>
</div><p>Contact: Emily Lorcheim, ClorDiSys, Phone: 908-236-4100, [email protected], 50 Tannery Rd, Suite 1, Branchburg, NJ 08876</p>
<div class="lb-trans"><p>联系方式：Emily Lorcheim，ClorDiSys，电话：908-236-4100，[email protected]，50 Tannery Rd, Suite 1, Branchburg, NJ 08876</p>
</div><p>SOURCE ClorDiSys Solutions Inc</p>
<div class="lb-trans"><p>来源：ClorDiSys Solutions Inc</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEwJk5ld3NJdGVtSWQ9Tlk4NDg4MyZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTAxMzAxUFJfTkVXU19VU1BSX19fX19OWTg0ODgz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY84883&amp;Transmission_Id=202602101301PR_NEWS_USPR_____NY84883&amp;DateId=20260210"/></p>

13:01 ETClordisys Strengthens Leadership Team with Addition of Former Sterigenics Leaders to Support Growth and Continued Scaling of Contract Sterilization Operations

Clordisys 通过引入前 Sterigenics 的领导者来加强其领导团队，以支持合同灭菌业务的增长和持续扩展